Detalles de la búsqueda
1.
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Thyroid
; 34(3): 347-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062732
2.
Intending to be a supervisor, mentor or coach? Which, what for and why?
Educ Prim Care
; 17(2): 109-116, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-28240065
Resultados
1 -
2
de 2
1
Próxima >
>>